Michael Boeckh Selected Research

maribavir

1/2020	Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.
1/2019	Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.
4/2011	Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.
6/2008	Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Boeckh Research Topics

Disease

68	Infections 01/2022 - 01/2002
21	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2003
19	Human Influenza (Influenza) 01/2022 - 11/2004
16	Virus Diseases (Viral Diseases) 01/2022 - 12/2002
15	Neutropenia 01/2020 - 02/2002
14	Cytomegalovirus Infections (Inclusion Disease) 11/2021 - 01/2002
12	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 09/2004
11	Viremia 01/2022 - 03/2002
11	Pneumonia (Pneumonitis) 12/2021 - 10/2003
11	Aspergillosis 01/2021 - 07/2004
9	Respiratory Tract Diseases (Respiratory Tract Disease) 10/2019 - 07/2011
8	Neoplasms (Cancer) 01/2022 - 09/2004
8	Lymphopenia (Lymphocytopenia) 12/2020 - 12/2002
7	COVID-19 01/2022 - 01/2020
7	Paramyxoviridae Infections (Parainfluenza) 01/2021 - 08/2009
6	Bronchiolitis Obliterans Syndrome 01/2021 - 12/2002
6	Respiratory Syncytial Virus Infections 12/2020 - 09/2004
5	Communicable Diseases (Infectious Diseases) 01/2021 - 11/2017
5	Respiratory Insufficiency (Respiratory Failure) 12/2020 - 03/2006
5	Disease Progression 01/2020 - 05/2003
4	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2002
4	Invasive Fungal Infections 01/2021 - 03/2009
4	Herpes Zoster 01/2021 - 01/2015
4	Leukemia 01/2016 - 10/2003
4	Mycoses (Diseases, Fungus) 01/2015 - 02/2004
3	Cytopenia 01/2022 - 12/2011
3	Herpes Simplex 11/2021 - 01/2015
3	Critical Illness (Critically Ill) 01/2017 - 07/2008
3	Chickenpox 02/2015 - 11/2006
2	Hyperglycemia 01/2022 - 01/2021
2	Hepatitis C 11/2021 - 01/2021
2	Sepsis (Septicemia) 01/2021 - 01/2017
2	Measles 01/2021 - 10/2020
2	Hemorrhagic Cystitis 01/2020 - 08/2005
2	Renal Insufficiency (Renal Failure) 01/2020 - 10/2003
2	Bacteremia 01/2020 - 01/2017
2	Late Onset Disorders 01/2019 - 10/2008
2	Vomiting 12/2017 - 06/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 08/2013
2	Thrombocytopenia (Thrombopenia) 12/2013 - 12/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2013 - 05/2006
2	Hypersensitivity (Allergy) 04/2012 - 07/2005
2	Hypoxia (Hypoxemia) 07/2011 - 05/2011
1	Hypoalbuminemia 01/2022
1	Persistent Infection 12/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Bone Marrow Failure Disorders 01/2021

Drug/Important Bio-Agent (IBA)

26	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2002
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2003
12	Ganciclovir (Cytovene)FDA LinkGeneric 11/2021 - 01/2002
8	SteroidsIBA 01/2022 - 10/2003
7	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2010
7	Oxygen (Dioxygen)IBA 01/2021 - 04/2013
5	VaccinesIBA 01/2022 - 04/2012
5	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2011 - 12/2002
4	maribavirIBA 01/2020 - 06/2008
4	Pharmaceutical PreparationsIBA 01/2020 - 02/2004
3	letermovirIBA 01/2021 - 12/2017
3	Ribavirin (Virazole)FDA LinkGeneric 12/2020 - 01/2007
3	Oseltamivir (Tamiflu)FDA Link 11/2020 - 11/2004
3	Prednisone (Sone)FDA LinkGeneric 01/2020 - 03/2009
3	Valganciclovir FDA Link 01/2020 - 09/2003
3	Acyclovir (Aciclovir)FDA LinkGeneric 03/2017 - 03/2003
3	Fluconazole (Zonal)FDA LinkGeneric 12/2010 - 02/2004
3	P 11 (P-11)IBA 12/2010 - 03/2002
2	oplunofuspIBA 01/2021 - 06/2015
2	Valacyclovir (Valtrex)FDA LinkGeneric 01/2021 - 03/2017
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	presatovirIBA 12/2020 - 12/2020
2	AntibodiesIBA 01/2020 - 05/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 11/2006
2	Cidofovir (Vistide)FDA Link 01/2019 - 03/2005
2	Viral DNAIBA 01/2019 - 08/2005
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2016 - 10/2015
2	AzolesIBA 12/2016 - 09/2004
2	BilirubinIBA 07/2015 - 02/2007
2	AntigensIBA 09/2013 - 11/2003
2	Viral RNAIBA 12/2012 - 05/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2011 - 02/2007
2	Voriconazole (Vfend)FDA LinkGeneric 12/2010 - 09/2004
2	GlucocorticoidsIBA 03/2009 - 04/2005
2	Itraconazole (Sporanox)FDA LinkGeneric 02/2004 - 02/2004
1	Cell-Free Nucleic AcidsIBA 12/2021
1	Ribonuclease P (RNase P)IBA 01/2021

Therapy/Procedure

54	Cell Transplantation 01/2022 - 12/2005
39	Therapeutics 01/2022 - 01/2002
38	Transplantation 01/2022 - 01/2002
15	Hematopoietic Stem Cell Transplantation 01/2020 - 05/2003
10	Artificial Respiration (Mechanical Ventilation) 12/2020 - 10/2003
7	Stem Cell Transplantation 03/2016 - 03/2002
4	Drug Therapy (Chemotherapy) 01/2018 - 02/2010
4	Immunotherapy 01/2018 - 01/2015
2	Homologous Transplantation 11/2021 - 06/2015
2	Self-Testing 01/2021 - 01/2020
2	Mechanical Ventilators (Ventilator) 01/2021 - 01/2017
2	Length of Stay 01/2017 - 07/2008
2	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 09/2002
1	Glycemic Control 01/2022
1	Treatment Delay 01/2021